123I-FP-CIT SPECT 可准确区分多系统萎缩的帕金森型与小脑型
该单中心13年回顾性队列研究纳入34例临床多系统萎缩患者(28例MSA-P、6例MSA-C),采用相同SPECT采集与重建方案,评估半定量123I-FP-CIT SPECT模式差异。MSA-P组所有感兴趣区摄取值更低、不对称指数更高、尾状核/壳核比值更高,两组半定量SPECT模式显著不同。
要点
- MSA-P组患侧更重侧纹状体摄取值1.10±0.51,低于MSA-C组的2.30±0.41(P=0.0005)。
- MSA-P组不对称指数24.7±24.8%,高于MSA-C组的6.3±4.5%(P=0.028)。
- MSA-P组尾状核/壳核比值2.26±1.23,高于MSA-C组的1.13±0.17(P=0.00148)。
核心结论
- MSA-P与MSA-C受试者呈现显著不同的半定量SPECT模式,MSA-P表现为严重摄取受损和高不对称性,MSA-C表现为临界摄取值。
- 作者认为临床区分这两种表型实体对于评估SPECT鉴别退行性帕金森综合征的潜力是必要的。
研究设计与样本
- 单中心13年(2003-2016)回顾性队列研究,纳入可能或很可能多系统萎缩且采用相同SPECT采集与重建方案扫描的受试者。
- 共识别34例临床多系统萎缩受试者(28例MSA-P和6例MSA-C),平均年龄68.2±10.1岁,男/女比例1.00,病程2.5±2.2年,运动障碍协会统一帕金森病评定量表III评分33.8±12.4。
- 纹状体感兴趣区年龄依赖性半定量参考限值、不对称指数和尾状核/壳核比值此前已在非退行性疾病且视觉扫描正常受试者队列中以百分位法建立。
主要发现
- MSA-P受试者所有感兴趣区摄取值均更低,例如患侧更重侧纹状体摄取值1.10±0.51,而MSA-C为2.30±0.41(P=0.0005)。
- MSA-P组不对称指数%为24.7±24.8,高于MSA-C组的6.3±4.5(P=0.028)。
- MSA-P组尾状核/壳核比值为2.26±1.23,高于MSA-C组的1.13±0.17(P=0.00148)。
关键数值与推荐
- MSA-P组患侧更重侧纹状体摄取值1.10±0.51 vs MSA-C组2.30±0.41(P=0.0005)。
- MSA-P组不对称指数24.7±24.8% vs MSA-C组6.3±4.5%(P=0.028)。
- MSA-P组尾状核/壳核比值2.26±1.23 vs MSA-C组1.13±0.17(P=0.00148)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Dopamine transporter SPECT imaging is a valuable tool to estimate the integrity of presynaptic dopaminergic pathways in degenerative parkinsonisms. Evidence about SPECT differential pattern between parkinsonian and cerebellar forms of multiple system atrophy (MSA-P and MSA-C) is lacking. We aimed at assessing whether MSA-P and MSA-C variants have a distinct semiquantitative I-FP-CIT SPECT pattern. METHODS: We studied a unicentric 13-year (2003-2016) retrospective cohort of subjects with possible or probable MSA and scanned with the same acquisition and reconstruction SPECT protocol. Age-dependent semiquantitative reference limits for striatal volumes of interest, asymmetry indices, and caudate/putamen ratio were previously established with a percentile approach on a cohort of subjects with nondegenerative conditions and normal visual scan. RESULTS: Thirty-four subjects with clinical MSA (28 MSA-P and 6 MSA-C) were identified (mean age, 68.2 ± 10.1 years; male/female ratio 1.00; disease duration, 2.5 ± 2.2 years; Movement Disorders Society Unified Parkinson's Disease Rating Scale III score, 33.8 ± 12.4). The MSA-P subjects exhibited lower uptake values for all volumes of interest, for example, striatal uptake on the more affected side (1.10 ± 0.51) compared with MSA-C (2.30 ± 0.41, P = 0.0005), as well as significantly higher asymmetry indices % (24.7 ± 24.8 vs 6.3 ± 4.5, P = 0.028) and caudate/putamen ratio (2.26 ± 1.23 vs 1.13 ± 0.17, P = 0.00148). CONCLUSIONS: The MSA-P and MSA-C subjects exhibited significantly distinct semiquantitative SPECT pattern with severe uptake impairment and high asymmetry for MSA-P and borderline uptake values for MSA-C. Clinical distinction of these 2 phenotypical entities is necessary in order to evaluate SPECT potential to discriminate between degenerative parkinsonisms.
引用
- Nicastro N, Garibotto V, Burkhard PR, et al. 123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy. Clin Nucl Med. 2018. PMID: 29215405. doi:10.1097/RLU.0000000000001899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。